Add Yahoo as a preferred source to see more of our stories on Google. With holiday parties in full gear, it's that time of year that will eventually lead to people getting sick. Feeling ill after that ...

We’re still in the early stages of RSV season, but doctors are already worried about a rise in cases. As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Every fall and winter, a familiar set of illnesses makes ...

Six recent studies conclude that maternal respiratory syncytial virus (RSV) vaccination and the long-acting monoclonal ...

Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being dangerous to babies and toddlers due to how often child-related RSV ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced positive top-line safety and immunogenicity results from substudy B of the ongoing pivotal Phase 3 clinical trial (NCT05842967) MONeT ...

A new immunisation program for pregnant mothers and newborns has almost halved the number of young babies being hospitalised ...

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 cause of hospitalization in infants. The US Food and Drug Administration ...

Immunization with the long-acting monoclonal antibody nirsevimab may provide stronger protection against hospitalizations for ...

Australia's new respiratory syncytial virus (RSV) immunization program cut hospital admissions for Australia's youngest ...

Doctors say the number of vaccinated mothers remains too low to show a measurable dip in infant hospitalisations.

Respiratory syncytial virus, or RSV, is a common virus that infects the nose, throat and lungs, according to the U.S. Centers for Disease Control and Prevention. Is it RSV, COVID or the flu? RSV ...